Preliminary activity in the first in human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Emma Jane Dean, Gerald Steven Falchook, Manish R. Patel, Andrew Jacob Brenner, Jeffrey R. Infante, Hendrik-Tobias Arkenau, Erkut Hasan Borazanci, Juanita Suzanne Lopez, Shubham Pant, Peter Schmid, Arthur E. Frankel, Suzanne Fields Jones, William McCulloch, George Kemble, Marie O'Farrell, Howard Burris
Institutions: University of Manchester, The Christie Hospital, The Christie NHS Foundation Trust, The University of Texas at San Antonio Health Science Center, Sarah Cannon, Sarah Cannon Research Institute, University College London, Translational Genomics Research Institute, Institute of Cancer Research, University of Oklahoma Health Sciences Center, University of Sussex, The University of Texas Southwestern Medical Center, Tennessee Oncology
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2751111146